Iran Says Strikes Hit Cancer Drug Company
US and Israeli strikes have damaged one of Iran’s largest pharmaceutical companies, according to the Iranian government, which said the facility produced cancer medicines, anaesthetics and other specialised drugs. Tehran said the strike hit a civilian-linked site and disrupted part of its medicine production capacity, adding a public health dimension to the widening conflict.
Iran Says Pharmaceutical Company Was Hit
Iran said the facility was struck on Tuesday morning during what it described as attacks on civilian centres. In a government statement, Tehran said the production line at the company was damaged. The report did not indicate the full scale of the disruption or whether operations at the wider site had been halted completely.
Cancer Drug And Anaesthetic Production Affected
Iranian officials said the company was a major producer of anti-cancer medicines, anaesthetic products and other specialised drugs. That has raised concern because any sustained damage to such a facility could affect access to critical treatment and hospital supplies at a time when the war is already straining essential services inside Iran.
State-Linked Ownership Draws Attention
Reports said the pharmaceutical company is owned by the Social Security Investment Company, a state-run holding firm that manages pension funds. That detail is likely to sharpen attention on whether the site was viewed as state-linked infrastructure or whether the strike risks wider criticism because of its role in producing civilian medicines. There was no immediate public confirmation from the United States or Israel in the material provided.
